Edwin Rock - Net Worth and Insider Trading

Edwin Rock Net Worth

The estimated net worth of Edwin Rock is at least $133,869 dollars as of 2024-05-06. Edwin Rock is the Chief Medical Officer of GlycoMimetics Inc and owns about 375,403 shares of GlycoMimetics Inc (GLYC) stock worth over $133,869. Details can be seen in Edwin Rock's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Edwin Rock has not made any transactions after 2023-09-22 and currently still holds the listed stock(s).

Transaction Summary of Edwin Rock

To

Edwin Rock Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Edwin Rock owns 1 companies in total, including GlycoMimetics Inc (GLYC) .

Click here to see the complete history of Edwin Rock’s form 4 insider trades.

Insider Ownership Summary of Edwin Rock

Ticker Comapny Transaction Date Type of Owner
GLYC GlycoMimetics Inc 2023-09-22 Chief Medical Officer

Edwin Rock Latest Holdings Summary

Edwin Rock currently owns a total of 1 stock. Edwin Rock owns 375,403 shares of GlycoMimetics Inc (GLYC) as of September 22, 2023, with a value of $133,869.

Latest Holdings of Edwin Rock

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GLYC GlycoMimetics Inc 2023-09-22 375,403 0.36 133,869

Holding Weightings of Edwin Rock


Edwin Rock Form 4 Trading Tracker

According to the SEC Form 4 filings, Edwin Rock has made a total of 3 transactions in GlycoMimetics Inc (GLYC) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in GlycoMimetics Inc is the acquisition of 65,403 shares on September 22, 2023, which cost Edwin Rock around $90,256.

Insider Trading History of Edwin Rock

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Edwin Rock Trading Performance

GuruFocus tracks the stock performance after each of Edwin Rock's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Edwin Rock is 10.2%. GuruFocus also compares Edwin Rock's trading performance to market benchmark return within the same time period. The performance of stocks bought by Edwin Rock within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Edwin Rock's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Edwin Rock

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.54
Relative Return to S&P 500(%) 7.77

Edwin Rock Ownership Network

Ownership Network List of Edwin Rock

No Data

Ownership Network Relation of Edwin Rock


Edwin Rock Owned Company Details

What does GlycoMimetics Inc do?

Who are the key executives at GlycoMimetics Inc?

Edwin Rock is the Chief Medical Officer of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include CFO Brian M. Hahn , SVP & Chief Commercial Officer Bruce S Johnson , and SVP and Chief Business Officer Chinmaya Rath .

GlycoMimetics Inc (GLYC) Insider Trades Summary

Over the past 18 months, Edwin Rock made 3 insider transaction in GlycoMimetics Inc (GLYC) with a net purchase of 375,403. Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net purchase of 2,026,717 shares made by Invus Public Equities, L.p. , a net sale of 4,121,511 shares made by Scott D Sandell , and a net purchase of 50,000 shares made by Daniel M Junius .

In summary, during the past 3 months, insiders sold 0 shares of GlycoMimetics Inc (GLYC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,125,211 shares of GlycoMimetics Inc (GLYC) were sold and 2,581,565 shares were bought by its insiders, resulting in a net sale of 1,543,646 shares.

GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

GlycoMimetics Inc Insider Transactions

No Available Data

Edwin Rock Mailing Address

Above is the net worth, insider trading, and ownership report for Edwin Rock. You might contact Edwin Rock via mailing address: 9708 Medical Center Drive, Rockville Md 20850.

Discussions on Edwin Rock

No discussions yet.